Search and analyze individual stocks with comprehensive metrics

WALPAR NUTRITIONS

WALPARPharmaceuticals
39.60+0.00 (+0.00%)
As on 02 Jan 2026, 04:16 pmMarket Open

Fundamental Score

...

WALPAR NUTRITIONS Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Average

Return on Equity

15.09%
Average

Return on Capital Employed

16.08%
Poor

Operating Profit Margin (5Y)

7.63%
Poor

Dividend Yield

0.00%

Valuation Metrics

Excellent

Price to Earnings

15.96x

Market Capitalization

37.19 (Cr)

Industry P/E

31.77x

Growth Metrics

Poor

YoY Quarterly Profit Growth

0.00%
Poor

YoY Quarterly Sales Growth

12.17%

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Financial Health

Average

Debt to Equity

0.48x
Excellent

Interest Coverage

12.64x
Poor

Free Cash Flow (5Y)

-5.97 (Cr)

Ownership Structure

Good

Promoter Holding

68.61%
Poor

FII Holding

0.00%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
68.61%
Promoter Holding
37.19 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of WALPAR across key market metrics for learning purposes.

Positive Indicators

6 factors identified

Strong Return on Equity (15.09%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (16.08%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Attractive Valuation (P/E: 15.96 vs Industry: 31.77)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Strong Interest Coverage (12.64x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Balanced Promoter Holding (68.61%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

3 factors identified

Negative Free Cash Flow (₹-5.97 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Loading Peer Comparison

Finding companies in the Pharmaceuticals sector...

Financial Statements

Comprehensive financial data for WALPAR NUTRITIONS

About WALPAR

Company Details

Symbol:WALPAR
Industry:Pharmaceuticals
Sector:Pharmaceuticals
Website:N/A

WALPAR Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)15.09%
Return on Capital Employed16.08%
Operating Profit Margin (5Y)7.63%
Debt to Equity Ratio0.48
Interest Coverage Ratio12.64

Growth & Valuation

Sales Growth (5Y)N/A%
Profit Growth (5Y)N/A%
EPS Growth (5Y)N/A%
YoY Quarterly Profit Growth0.00%
YoY Quarterly Sales Growth12.17%

Frequently Asked Questions

What is the current price of WALPAR NUTRITIONS (WALPAR)?

As of 02 Jan 2026, 04:16 pm IST, WALPAR NUTRITIONS (WALPAR) is currently trading at ₹39.60. The stock has a market capitalization of ₹37.19 (Cr).

Is WALPAR share price Overvalued or Undervalued?

WALPAR is currently trading at a P/E ratio of 15.96x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the WALPAR NUTRITIONS share price?

Key factors influencing WALPAR's price include its quarterly earnings growth (Sales Growth: 12.17%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is WALPAR NUTRITIONS a good stock for long-term investment?

WALPAR NUTRITIONS shows a 5-year Profit Growth of N/A% and an ROE of 15.09%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.48 before investing.

How does WALPAR NUTRITIONS compare with its industry peers?

WALPAR NUTRITIONS competes with major peers in the Pharmaceuticals. Investors should compare WALPAR's P/E of 15.96x and ROE of 15.09% against the industry averages to determine its competitive standing.

What is the P/E ratio of WALPAR and what does it mean?

WALPAR has a P/E ratio of 15.96x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹16 for every ₹1 of annual earnings.

How is WALPAR performing according to Bull Run's analysis?

WALPAR has a Bull Run fundamental score of 34.5/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does WALPAR belong to?

WALPAR operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting WALPAR NUTRITIONS.

What is Return on Equity (ROE) and why is it important for WALPAR?

WALPAR has an ROE of 15.09%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently WALPAR NUTRITIONS generates profits from shareholders' equity.

How is WALPAR's debt-to-equity ratio and what does it indicate?

WALPAR has a debt-to-equity ratio of 0.48, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.

What is WALPAR's dividend yield and is it a good dividend stock?

WALPAR offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has WALPAR grown over the past 5 years?

WALPAR has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%.

What is the promoter holding in WALPAR and why does it matter?

Promoters hold 68.61% of WALPAR shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is WALPAR's market capitalization category?

WALPAR has a market capitalization of ₹37 crores, placing it in the Small-cap category.

How volatile is WALPAR stock?

WALPAR has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for WALPAR?

WALPAR has a 52-week high of ₹N/A and low of ₹N/A.

What is WALPAR's operating profit margin trend?

WALPAR has a 5-year average Operating Profit Margin (OPM) of 7.63%, indicating the company's operational efficiency.

How is WALPAR's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 12.17% and YoY Profit Growth of 0.00%.

What is the institutional holding pattern in WALPAR?

WALPAR has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.